Artal Group S.A. - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2019$16,982,000
+87.9%
350,000
+75.0%
0.68%
+254.7%
Q2 2018$9,040,000
-6.4%
200,0000.0%0.19%
+58.7%
Q1 2018$9,660,000
-29.9%
200,000
-42.9%
0.12%
-41.8%
Q4 2017$13,773,000
-19.4%
350,000
-36.4%
0.21%
-29.3%
Q3 2017$17,078,000
+78.4%
550,000
+57.1%
0.29%
+76.0%
Q2 2017$9,573,000
+48.4%
350,000
+100.0%
0.17%
+16.8%
Q1 2017$6,449,000
+81.4%
175,000
-28.9%
0.14%
+81.0%
Q4 2016$3,555,000
+54.2%
246,054
+146.1%
0.08%
+71.7%
Q3 2016$2,305,000
+11.1%
100,000
-20.0%
0.05%
+7.0%
Q2 2016$2,074,000125,0000.04%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2019
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$680.00%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders